Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, California 92121, USA.
Nature. 2011 Jul 27;475(7357):519-23. doi: 10.1038/nature10226.
EBI2 (also called GPR183) is an orphan G-protein-coupled receptor that is highly expressed in spleen and upregulated upon Epstein-Barr-virus infection. Recent studies indicated that this receptor controls follicular B-cell migration and T-cell-dependent antibody production. Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol metabolism. The biological effects of oxysterols have largely been credited to the activation of nuclear hormone receptors. Here we isolate oxysterols from porcine spleen extracts and show that they are endogenous ligands for EBI2. The most potent ligand and activator is 7α,25-dihydroxycholesterol (OHC), with a dissociation constant of 450 pM for EBI2. In vitro, 7α,25-OHC stimulated the migration of EBI2-expressing mouse B and T cells with half-maximum effective concentration values around 500 pM, but had no effect on EBI2-deficient cells. In vivo, EBI2-deficient B cells or normal B cells desensitized by 7α,25-OHC pre-treatment showed reduced homing to follicular areas of the spleen. Blocking the synthesis of 7α,25-OHC in vivo with clotrimazole, a CYP7B1 inhibitor, reduced the content of 7α,25-OHC in the mouse spleen and promoted the migration of adoptively transferred pre-activated B cells to the T/B boundary (the boundary between the T-zone and B-zone in the spleen follicle), mimicking the phenotype of pre-activated B cells from EBI2-deficient mice. Our results show an unexpected causal link between EBI2, an orphan G-protein-coupled receptor controlling B-cell migration, and the known immunological effects of certain oxysterols, thus uncovering a previously unknown role for this class of molecules.
EBI2(也称为 GPR183)是一种孤儿 G 蛋白偶联受体,在脾脏中高度表达,并在 Epstein-Barr 病毒感染时上调。最近的研究表明,该受体控制滤泡 B 细胞迁移和 T 细胞依赖性抗体产生。氧化固醇对免疫和炎症反应以及胆固醇代谢有深远的影响。氧化固醇的生物学效应在很大程度上归因于核激素受体的激活。在这里,我们从猪脾脏提取物中分离出氧化固醇,并证明它们是 EBI2 的内源性配体。最有效的配体和激活剂是 7α,25-二羟基胆固醇(OHC),其对 EBI2 的解离常数为 450 pM。在体外,7α,25-OHC 以约 500 pM 的半数最大有效浓度值刺激表达 EBI2 的小鼠 B 和 T 细胞的迁移,但对缺乏 EBI2 的细胞没有影响。在体内,EBI2 缺陷型 B 细胞或用 7α,25-OHC 预处理使其失敏的正常 B 细胞显示出向脾脏滤泡区归巢减少。用 CYP7B1 抑制剂克霉唑在体内阻断 7α,25-OHC 的合成,降低了小鼠脾脏中 7α,25-OHC 的含量,并促进了过继转移的预激活 B 细胞向 T/B 边界(脾脏滤泡中 T 区和 B 区之间的边界)的迁移,模拟了缺乏 EBI2 的小鼠的预激活 B 细胞的表型。我们的结果表明,控制 B 细胞迁移的孤儿 G 蛋白偶联受体 EBI2 与某些氧化固醇的已知免疫作用之间存在意外的因果关系,从而揭示了这类分子的一个以前未知的作用。